Wolf-Ruediger Ulrich

Title: Wolf-Ruediger Ulrich: Innovator in iNOS Inhibitors

Introduction

Wolf-Ruediger Ulrich is a notable inventor based in Constance, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as inducible nitric oxide synthase (iNOS) inhibitors. With a total of 4 patents to his name, Ulrich's work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents, Ulrich has developed imidazopyridine-derivatives that act as effective iNOS inhibitors. The compounds of formula (I), in which R1, R2, R3, R4, R5, and A have specific meanings as described in the patent, represent a novel approach to inhibiting iNOS. These compounds are designed to provide therapeutic benefits in conditions where nitric oxide plays a detrimental role.

Career Highlights

Throughout his career, Ulrich has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Altana Pharma AG and Nycomed GmbH, where he contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing the understanding and application of iNOS inhibitors.

Collaborations

Ulrich has collaborated with several professionals in his field, including his coworker Thomas Martin. Their joint efforts have led to advancements in the development of innovative therapeutic compounds.

Conclusion

Wolf-Ruediger Ulrich's contributions to the field of medicinal chemistry, particularly in the area of iNOS inhibitors, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.